Retinal Tissue Differentiation via Staged Floating Stem Cell Culture
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing retinal tissue and retinal pigment epithelium from pluripotent stem cells are inefficient, lacking high-yield processes.
Innovation Solution
A method involving floating culture of pluripotent stem cells in serum-free and serum-containing media with specific signal pathway inhibitors and basement membrane preparations to form aggregates and structures such as retinal tissues and optic-cup-like structures.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional methods are used to produce retinal tissue from pluripotent stem cells, then the production process is simple, but the production efficiency is low
Solution Approach 1:
The culture process is divided into distinct stages: aggregate formation stage (serum-free medium with Wnt inhibitor), retinal tissue differentiation stage (serum-containing medium with FGF and Shh agonist), and maturation stage. Each stage uses specific culture conditions and additives to achieve efficient production of retinal pigment epithelium and neural retina
Solution Approach 2:
The invention changes multiple culture parameters including medium composition (serum-free to serum-containing transition), growth factor concentrations (FGF, Shh agonist), and additive types (Wnt inhibitors, Nodal inhibitors) to optimize production efficiency at each developmental stage
2Productivity
If pluripotent stem cells are differentiated into retinal pigment epithelium using conventional methods, then the process is straightforward, but the efficiency is insufficient
Solution Approach 1:
The invention performs preliminary aggregate formation in serum-free medium with Wnt inhibitors before transitioning to serum-containing medium for differentiation. This preliminary organization of pluripotent stem cells into aggregates pre-establishes the structural foundation needed for efficient retinal pigment epithelium differentiation
Solution Approach 2:
The differentiation process maintains continuous exposure to growth factors (FGF, Shh agonist) and culture additives throughout the transition from aggregate formation to retinal pigment epithelium differentiation, ensuring uninterrupted and efficient differentiation without time loss
3Reliability
If retinal tissue is produced for transplantation, then the tissue must be functional, but the production yield is low
Solution Approach 1:
The invention uses Nodal inhibitors to control and feedback-regulate the differentiation process, ensuring that retinal pigment epithelium and neural retina differentiate in the correct proportions and maintain functional integrity suitable for transplantation while maximizing overall yield
Data Source
AI summary
The invention provides a method for producing a retinal tissue by (1) subjecting pluripotent stem cells to floating culture in a serum-free medium containing a substance inhibiting the Wnt signal pathway to form an aggregate of pluripotent stem cells, (2) subjecting the aggregate to floating culture in a serum-free medium containing a basement membrane preparation, and then (3) subjecting the aggregate to floating culture in a serumcontaining medium. The invention also provides a method for producing an optic-cup-like structure, a method for producing a retinal pigment epithelium, and a method for producing a retinal layer-specific neural cell.